December 15, 2020
Pfizer/BioNTech vaccine reaches 141 of 145 first-day locations
Editor's Note
The first batch of the Pfizer/BioNTech's newly authorized COVID-19 vaccine for emergency use reached 141 of 145 targeted locations on the first day of its national rollout, a Department of Health and Human Services spokeswoman told Reuters.
Four island territories—American Samoa, Guam, North Mariana Islands, and the US Virgin Islands—are still to receive their supplies.
The federal government plans to distribute 2.9 million vaccine doses to 636 locations by week’s end, the December 14 Reuters reports.
Free Daily News
- 7 strategies healthcare leaders can use to turn around toxic workplace culture
- Nutrition screening tool predicts poor outcomes after pancreatic cancer surgery
- CDC reports 460% surge in drug-resistant NDM-CRE infections
- 5 reasons why perioperative leaders deserve to attend the 2025 OR Manager Conference
- Global medical community rejects Trump’s Tylenol-autism claims: Statements compilation
- Surgery, implantable devices offer new hope for drug-resistant epilepsy
- Remote monitoring speeds recovery, lowers complications after cancer surgery
- Common supplements may heighten bleeding risk during surgery, Polish study finds
- Keeping sensory aids in place during surgery reduces delirium risk in older hip fracture patients
- HFMA warns affordability crisis is driving up provider bad debt
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement